Pharmaceuticals
US regulators grant conditional approval to Abbott’s acquisition of St. Jude Medical
28 Dec 2016
US antitrust regulators yesterday approved Abbott Laboratories proposed $25-billion acquisition of medical device maker St. Jude Medical Inc on condition that it divests two medical device businesses